Lung cancer: open trials in Thailand

32 open trials have a site in Thailand. Registry data; only the trial team decides who can take part.

NCT07361497
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Bangkok · Chiang Mai · Khon Kaen · Songkhla
Registry updated 2026-11-05
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Songkhla
Registry updated 2026-11-03
NCT06170788
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Faculty of Medicine Siriraj Hospital ( Site 4000), Bangkok · Maharaj Nakorn Chiang Mai Hospital ( Site 4001), Muang · Chulalongkorn University ( Site 4003), Pathumwan
Registry updated 2026-11-03
NCT07699328
A Study of VRN110755 in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
Trial Treatment · Phase 1/2 · Voronoi, Inc
Songklanagarind Hospital Prince of Songkla University, Hat Yai · Phramongkutklao Hospital, Thung Phaya Thai
Registry updated 2026-11-03
NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Trial Treatment · Phase 2/3 · BioNTech SE
Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok · Chulalongkorn University, Bangkok · Chiangrai Prachanukroh Hospital, Chiang Rai · Lampang Cancer Hospital, Lampang · HRH Princess MahaChakri Sirindhorn Medical Center - Srinakharinwirot University, Nakhon Nayok · Rajavithi Hospital, Ratchathewi
Registry updated 2026-11-02
NCT07185997
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Trial Treatment · Phase 3 · ArriVent BioPharma, Inc.
Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok · Mahidol University - Siriraj Hospital, Bangkoknoi · Prince of Songkla Hospital, Hat Yai · Chulabhorn Hospital, Lak Si
Registry updated 2026-11-02
NCT04613596
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Trial Treatment · Phase 2/3 · Mirati Therapeutics Inc.
Chulabhorn Hospital, Bangkok · Navamindradhiraj University - Faculty of Medicine Vajira Hospital, Bangkok
Registry updated 2026-10-30
NCT06623422
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Faculty of Medicine Siriraj Hospital ( Site 2403), Bangkoknoi · Songklanagarind Hospital ( Site 2402), Hat Yai · Faculty of Medicine - Khon Kaen University ( Site 2401), Muang · Maharaj Nakorn Chiang Mai Hospital ( Site 2404), Muang · Ramathibodi Hospital ( Site 2405), Ratchathewi
Registry updated 2026-10-30
NCT06422143
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2300), Bangkok · Faculty of Medicine Siriraj Hospital ( Site 2301), Bangkoknoi · Songklanagarind hospital ( Site 2303), Hat Yai · Lampang Cancer Hospital ( Site 2304), Lampang · Faculty of Medicine - Khon Kaen University ( Site 2305), Muang · Maharaj Nakorn Chiang Mai Hospital ( Site 2302), Muang · Prapokklao Hospital ( Site 2306), Mueang
Registry updated 2026-10-29
NCT06692738
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · AstraZeneca
Bangkok · Chiang Mai · Dusit · Nakhon Ratchasima · Songkhla
Registry updated 2026-10-29
NCT06357533
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Trial Treatment · Phase 3 · AstraZeneca
Bangkok · Hat Yai · Muang · Mueang
Registry updated 2026-10-28
NCT06627647
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Trial Treatment · Phase 3 · AstraZeneca
Bangkok · Chiang Mai · Dusit · Nakhon Ratchasima · Songkhla
Registry updated 2026-10-28
NCT06996782
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 1/2 · AstraZeneca
Bangkok · Chanthaburi · Hat Yai · Khon Kaen · Rachathewi
Registry updated 2026-10-28
NCT07472517
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Trial Treatment · Phase 3 · Boehringer Ingelheim
Vajira Hospital, Bangkok · Siriraj Hospital, Bangkok · Maharaj Nakom Chiangmai Hospital, Chiang Mai · Songklanagarind Hospital, Hat Yai
Registry updated 2026-10-28
NCT06875310
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Trial Treatment · Phase 3 · Mirati Therapeutics Inc.
Chulalongkorn University, Bangkok · Songklanagarind Hospital, Hat Yai · Faculty of Medicine - Khon Kaen University, Muang
Registry updated 2026-10-27
NCT07680790
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Bangkok · Din Daeng
Registry updated 2026-10-26
NCT05920356
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Trial Treatment · Phase 3 · Amgen
Phramongkutklao Hospital, Bangkok · King Chulalongkorn Memorial Hospital, Bangkok · Vajira Hospital, Bangkok · Maharaj Nakorn Chiang Mai Hospital, Chiang Mai · Srinagarind Hospital, Khon Kaen · Banphaeo General Hospital, Samut Sakhon · Songklanagarind Hospital, Songkhla
Registry updated 2026-10-23
NCT06899126
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Trial Treatment · Phase 3 · Daiichi Sankyo
Siriraj Hospital, Bangkok · Phramongkutklao Hospital, Bangkok · Vajira Hospital, Dusit · Songklanagarind Hospital, Hat Yai · Chulabhorn Hospital, Laksi · Rajavithi Hospital, Rajathevee
Registry updated 2026-10-23
NCT07063745
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Chulalongkorn University, Bangkok · Faculty of Medicine Siriraj Hospital, Bangkok
Registry updated 2026-10-23
NCT07361510
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Bangkok · Chiang Mai · Khon Kaen · Songkhla
Registry updated 2026-10-23
NCT07227597
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 3002), Bangkok · Faculty of Medicine Siriraj Hospital ( Site 3000), Bangkoknoi · Songklanagarind hospital ( Site 3001), Hat Yai
Registry updated 2026-10-20
NCT07098338
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 2 · AstraZeneca
Bangkok · Banphaeo
Registry updated 2026-10-15
NCT05123482
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Bangkok · Chiang Mai
Registry updated 2026-10-13
NCT07128199
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Trial Treatment · Phase 3 · Taiho Oncology, Inc.
Chulabhorn Hospital, Bang Kapi · Navamindradhiraj University - Faculty of Medicine Vajira Hospital, Bangkok · Faculty of Medicine Siriraj Hospital, Bangkoknoi · Songklanagarind Hospital, Hat Yai · Lampang Cancer Hospital, Muang · King Chulalongkorn Memorial Hospital, Pathum Wan
Registry updated 2026-10-13
NCT07291037
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Trial Treatment · Phase 3 · AstraZeneca
Bangkok · Hat Yai · Muang
Registry updated 2026-10-13

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error